Product Specification
Host |
Mouse |
Antigen |
CD19 |
Synonyms |
B-lymphocyte antigen CD19, LE-CD19, B-lymphocyte surface antigen B4, Differentiation antigen CD19, T-cell surface antigen Leu-12 |
Immunogen |
Recombinant Protein |
Location |
Cell membrane |
Accession |
P15391 |
Clone Number |
S-1039-46 |
Antibody Type |
Mouse mAb |
Isotype |
IgG1,k |
Application |
FCM |
Reactivity |
Hu |
Purification |
Protein G |
Concentration |
0.2mg/ml |
Conjugation |
FITC |
Physical Appearance |
Liquid |
Storage Buffer |
PBS, 25% Glycerol, 1% BSA, 0.3% Proclin 300 |
Stability & Storage |
12 months from date of receipt / reconstitution, 2 to 8 °C as supplied. |
Dilution
application |
dilution |
species |
FCM |
5 μl per million cells in 100μl volume |
|
Background
The CD19 antigen plays an important role in clinical oncology. In normal cells, it is the most ubiquitously expressed protein in the B lymphocyte lineage. CD19 expression is induced at the point of B lineage commitment during the differentiation of the hematopoietic stem cell, and its expression continues through preB and mature B cell differentiation until it is finally down-regulated during terminal differentiation into plasma cells. CD19 expression is maintained in B-lineage cells that have undergone neoplastic transformation, and therefore CD19 is useful in diagnosis of leukemias and lymphomas using monoclonal antibodies (mAbs) and flow cytometry.